India Medicine Prices
-
{
- All
- News
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
Doctor Sounds Alarm on 'Predatory Pricing' In Private Hospitals: "Rs 64,000 For 3-Day Treatment"
The doctor criticised corporate hospital chains for acting as a "financial sinkhole" by inflating medicine prices and prescribing redundant tests.
-
Foreign Woman 'Shocked' By Medicine Prices In India: 'I Am Moving Here'
A foreigner was pleasantly surprised after she bought cough syrup and tablets in India for just Rs 252.
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
'I Am Shocked': Foreigner After Comparing Indian Medicine Prices To US And Australia
A foreigner went viral after praising India's affordable medicines, showing price comparisons with the US and Australia in a social media video.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
What Should You Avoid After A Stent Implant? Cardiologist Shares Tips For A Healthy Heart
The procedure to place a stent, often called angioplasty, is performed to restore proper blood flow, reduce symptoms (like chest pain), and lower the risk of heart attacks.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
Doctor Sounds Alarm on 'Predatory Pricing' In Private Hospitals: "Rs 64,000 For 3-Day Treatment"
The doctor criticised corporate hospital chains for acting as a "financial sinkhole" by inflating medicine prices and prescribing redundant tests.
-
Foreign Woman 'Shocked' By Medicine Prices In India: 'I Am Moving Here'
A foreigner was pleasantly surprised after she bought cough syrup and tablets in India for just Rs 252.
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
'I Am Shocked': Foreigner After Comparing Indian Medicine Prices To US And Australia
A foreigner went viral after praising India's affordable medicines, showing price comparisons with the US and Australia in a social media video.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
What Should You Avoid After A Stent Implant? Cardiologist Shares Tips For A Healthy Heart
The procedure to place a stent, often called angioplasty, is performed to restore proper blood flow, reduce symptoms (like chest pain), and lower the risk of heart attacks.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
